Images List Premium Download Classic

Cancer

Cancer-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Self-repairing digital device with real-time circuit switching inspired by attractor-conversion characteristics of a cancer cell
October 18, 2018 - N°20180302092

An electric device, which includes a first switch-unit providing a first internal circuit signal, a first delay circuit unit outputting a second internal circuit signal which is generated by delaying the first internal circuit signal, a first and logic outputting a first repair-signal generated by a logical and operation between the first internal circuit signal and the second internal circuit ...
Method for determining cancer
October 18, 2018 - N°20180299453

The present invention relates to a method for determining cancer, the method comprising the steps of: measuring free pd-l1 (programmed cell death-ligand 1) and free pd-1 (programmed cell death-1) as free protein markers in a liquid sample collected from a subject, and determining whether or not the liquid sample is a sample collected from a subject suffering from cancer, based on ...
Tpm4-alk fusion protein and composition for diagnosing cancer
October 18, 2018 - N°20180299451

Result: a tropomyosin 4 (tpm4)-anaplastic lymphoma receptor tyrosine kinase (alk) fusion protein, which is not expressed in a normal gastric tissue, but expressed only in a gastric cancer tissue, is identified. As a result identified by the tpm4 antibody, a high-molecular tpm4 band is present only in a gastric cancer tissue..
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Colorectal cancer screening method
October 18, 2018 - N°20180299448

Provided is a colorectal cancer inspection method by which the presence of early colorectal cancer at any one of stages from 0 to 2 can be accurately determined. The colorectal cancer inspection method includes: measuring the amounts of at least lactic acid, pyruvic acid, and glycolic acid among a plurality of kinds of in vivo metabolites contained in a biological sample collected ...
Cervical cancer testing method and test reagent used therefor
October 18, 2018 - N°20180299447

The present invention aims to provide a novel test method for evaluating the possibility of cervical cancer and a novel test reagent for use in the method. The present invention provides a test method for evaluating the possibility of cervical cancer, including the step of: detecting the muc expression in a biological sample isolated from the uterine cervix..
Profiling peptides and methods for sensitivity profiling
October 18, 2018 - N°20180299432

The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an mcl-1 binding domain, and optionally a cellular uptake moiety.
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Methods for detection of markers bladder cancer and inflammatory conditions of the bladder
October 18, 2018 - N°20180298452

Embodiments of this invention include methods for detection of markers of bladder cancer and inflammatory conditions of the bladder. Particularly, methods include detection of expression of certain genetic markers for bladder cancer and markers for detection of inflammatory conditions of the bladder.
Immunomodulatory rna
October 18, 2018 - N°20180298450

The present invention includes methods for detecting cancer in a subject and measuring the effectiveness of a cancer treatment. In certain embodiments, the invention includes assessing the level of unshielded rn7sl1 rna in a sample from a subject..
Gene expression profiles and uses thereof in breast cancer
October 18, 2018 - N°20180298449

A method for predicting the likelihood of locoregional recurrence (lrr) and/or distant metastasis in a subject with breast cancer following mastectomy and/or breast conserving surgery, comprising: measuring the expression level of at least one gene in a sample isolated from the subject; and deriving a score based on the measured expression level of the at least one gene, ...
Methods for assessing the treatment response of cancer patients and for treating cancer patients by ...
October 18, 2018 - N°20180298447

The present invention relates to the field of pharmacogenomics and in particular to assessing the response of a cancer patient to a treatment by analysing cpg methylation in the shox2 gene. Depending on the result of the analysis, the treatment can be continued or altered, thereby exploiting the therapeutic window better than conventional methods of assessing a treatment response..
Methods for detecting or quantifying ctp and ctp synthase activity
October 18, 2018 - N°20180298420

The present invention relates to a method for detecting or quantifying ctp in a cell sample comprising at least two nucleotide triphosphates by cationic ion pairing chromatography coupled to mass spectrometry, to a method for detecting or quantifying ctp synthase activity based on the method for detecting or quantifying ctp, and to their use in methods for screening potential immunosuppressive ...
Genetic variations associated with drug resistance
October 18, 2018 - N°20180298387

Methods and compositions are provided to determine if a cancer is resistant to treatment with anti-mitotic agents, including treatment with t-dm1. The methods relate to determining if the abcc3 gene is amplified and/or overexpressed in the cancer..
Methods and compositions involving transmembrane and coiled-coil domains 3 (tm-co3) in cancer
October 18, 2018 - N°20180298386

Certain embodiments provide methods and compositions related to clinical management of cancer patients based on the expression level of tmco3. Further embodiments involve methods and compositions related to treatment of cancer patients or patients determined to have an increased tmco3 level relative to a control or a reference level that is normal or indicating favorable prognosis..
Cancer Patent Pack
Download 198+ patent application PDFs
Cancer Patent Applications
Download 198+ Cancer-related PDFs
For professional research & prior art discovery
inventor
  • 198+ full patent PDF documents of Cancer-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Adhesive signature-based methods for the isolation of cancer-associated cells and cells derived therefrom
October 18, 2018 - N°20180298345

The present invention provides methods of isolating a cancer-associated cell, such as a cancer stem cell or tumor initiating cell or a cell derived therefrom, from a mixture of cells, for example, a mixture of adherent cells in culture. Cell isolation is achieved by the application of selective detachment forces..
Systems for detecting, monitoring or treating diseases or conditions using engineered cells and methods for ...
October 18, 2018 - N°20180298340

Provided are methods for detecting and treating disease states, including cancer, diabetes, fibrosis, and autoimmune diseases, by detecting increased mechanical modulus, or stiffness, or targeting tissues having increased mechanical modulus, or stiffness. Practicing these methods provides specific and localized detection assays and therapies for these disease states.
T cells with increased immunosuppression resistance
October 18, 2018 - N°20180298338

This invention relates to the treatment of cancer in an individual by administration of a population of modified t cells that express a recombinant camp phosphodiesterase (pde) or a fragment thereof and an antigen receptor which binds specifically to cancer cells in the individual. Populations of modified t cells and methods of producing populations of modified t cells are provided, ...
Method of nociceptor differentiation of human embryonic stem cells and uses thereof
October 18, 2018 - N°20180298326

The present invention relates to the field of stem cell biology, in particular the lineage specific differentiation of pluripotent or multipotent stem cells, which can include, but is not limited to, human embryonic stem cells (hesc), human induced pluripotent stem cells (hipsc), somatic stem cells, cancer stem cells, or any other cell capable of lineage specific differentiation. Specifically described are ...
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
October 18, 2018 - N°20180298109

This invention relates to a novel target for production of immune and non-immune based therapeutics and for disease diagnosis. More particularly, the invention provides therapeutic antibodies against vsig1, ildr1, loc253012, ai216611, c1orf32 or fxyd3 antigens, which are predicted co-stimulatory family members and which are differentially expressed in cancers including, lung cancer, ovarian cancer, and colon cancer, and diagnostic and ...
Therapeutic antibodies and their uses
October 18, 2018 - N°20180298108

The present invention relates to antibodies, e.g., full length antibodies or antigen binding fragments thereof, that specifically bind to bcma (b-cell maturation antigen) and/or cd3 (cluster of differentiation 3). The invention also relates to antibody conjugates (e.g., antibody-drug-conjugates) comprising the bcma antibodies, compositions comprising the bcma antibodies, and methods of using the bcma antibodies and their conjugates for ...
Inhibition of cytokine-induced sh2 protein in nk cells
October 18, 2018 - N°20180298101

The present invention relates to therapeutic and prophylactic methods based on inhibition of cis in nk cells. In particular, the present invention relates to treating or preventing a nk-responsive condition by administering to a subject a cis inhibitor, or administering cis-inhibited nk cells.
Combination therapy for the treatment of cancer
October 18, 2018 - N°20180298100

This invention relates to a pharmaceutical composition that comprises a first molecule that specifically binds her2/neu and a second molecule that specifically binds a cell-surface receptor (or its ligand) that is involved in regulating an immune checkpoint (or the ligand thereof). The invention particularly relates to the embodiment wherein the second molecule binds to pd-1.
Loading